The drama is reaching its breaking point for Bravo fans tonight as “Summer House” season 10 reunion part 3 airs Tuesday, June 9 at 8 p.m. Eastern. Tonight’s installment closes out one of the most ...

Because the episode airs on Bravo, any live-TV streaming service that carries the network—including DIRECTV, Sling, and the Disney+/Hulu + Live TV bundle—will offer a real-time viewing option. What ...

Bravo’s reality TV hit, “Summer House,” follows a group of New Yorker City residents who spend the warmer months escaping to the Hamptons. While sharing an annual summer rental, the cast members blow ...

The third and final part of Reckless Ben's investigation into the missing $200,000 Lego Star Wars collection may never see the light of day Lego Star Wars YouTube Reckless Ben’s investigation into the ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. With two games in the bag, the finale of the Final Fantasy Remake ...

We’ve finally gotten our first glimpse at the final chapter of Final Fantasy 7 remake trilogy. Square Enix debuted its first footage for the RPG, which finally revealed the game’s official title: ...

FFVII Rebirth left off at a critical part of the main story. We ended up seeing a major interaction between Sephiroth and Aerith. Which means when the adventure continues, it seems Cloud, Tifa, Barret ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

We know that part three is currently in development at Square Enix. Back in May, game director Naoki Hamaguchi told Nintendo Life in May that he had already completed “40 full playthroughs” of the ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously ...